Key Takeaways
- Shares of Enova International plummeted 25% to $169.15 on Tuesday, marking the steepest single-session decline since March 2020.
- The financial services firm pulled its regulatory filings with the OCC and Federal Reserve tied to its Grasshopper Bancorp acquisition.
- The transaction, first revealed in December 2025, carried a $369 million valuation.
- Chief Executive Steve Cunningham blamed ambiguous regulatory frameworks for nonbank institutions attempting to enter the banking sector.
- Citizens lowered its ENVA price objective from $270 to $215 while keeping its Market Outperform recommendation.
Enova International (ENVA) experienced a brutal trading session on Tuesday. Shares plunged 25% to close at $169.15, recording the company’s steepest single-day percentage loss since March 18, 2020, based on data from Dow Jones Market Data.
v
Enova International, Inc., ENVA
The sharp decline followed Enova’s Monday evening disclosure that it had pulled its pending regulatory submissions with both the Office of the Comptroller of the Currency and the Board of Governors of the Federal Reserve System.
These filings were directly connected to the company’s proposed $369 million takeover of Grasshopper Bancorp, a digitally-focused commercial banking institution. By withdrawing the applications, Enova effectively terminated the transaction.
The Grasshopper acquisition was initially unveiled in December 2025 and had been awaiting regulatory clearance ever since.
In a statement, CEO Steve Cunningham defended the withdrawal. “After a thorough evaluation, we are confident that withdrawing our applications is the best decision for Enova and our shareholders,” he explained in the official announcement.
Cunningham further highlighted regulatory ambiguity as a primary concern. “Regulators do not have clear standards for nonbanks that want to become banks and that serve customers whose credit needs today are met mostly outside of the banking system,” he stated.
Enova declined to identify specific regulatory objections. The company indicated the withdrawal came after minimal advancement in the approval process.
Analyst Adjusts Price Forecast
Following the announcement, a Citizens analyst reduced the price target for ENVA to $215 from a previous $270, though the firm preserved its Market Outperform designation on the shares.
The analyst observed that ENVA shares were trading down approximately 20% to around $180 in premarket activity following the disclosure. The actual closing decline approached 25%.
Citizens referenced InvestingPro analysis suggesting the stock trades above its Fair Value estimate, though the company’s PEG ratio of 0.36 indicates attractive valuation when accounting for growth rates.
Robust Financial Performance Continues
The collapsed transaction notwithstanding, Enova’s core operations have delivered solid results. The firm posted adjusted earnings of $4.31 per share on $929 million in revenue during its second quarter of 2026.
Those figures surpassed analyst consensus expectations of $3.96 per share on $909.61 million in revenue.
The results also represented the eighth consecutive quarter of earnings per share expansion exceeding 30%, with Citizens previously highlighting momentum across both consumer and small-business lending segments.
Despite Tuesday’s selloff, ENVA shares remain 7.6% higher year-to-date and have appreciated approximately 40% over the trailing twelve-month period.
The company’s market capitalization currently sits near $5.64 billion, with shares trading at a P/E multiple of 16.72.
Citizens retained its Market Outperform stance despite lowering the price target, pointing to continued growth opportunities for the business.
Get 3 Free Stock Ebooks
Discover top-performing stocks in AI, Crypto, and Technology with expert analysis.
- Top 10 AI Stocks - Leading AI companies
- Top 10 Crypto Stocks - Blockchain leaders
- Top 10 Tech Stocks - Tech giants
